‘Drug for a drug’ alcohol market: $1.3billion by 2033

The global Alcohol Use Disorder Treatment Market is projected to rise from $700million in 2023 to $1,300million by 2033, according to Future Markets. Players include Alkermes, Teva Pharmaceutical, BioCorRx, Adial, Addex Therapeutics, Kinnov, Opiant, Omeros, GlaxoSmithKline and Merck.